Pharmaceutical News and Articles

FDA Approves Yesintek (ustekinumab-kfce), a Biosimilar to Stelara

Lantern Pharma's Investigational Drug-Candidate, LP-184, Receives Second Fast Track Designation from FDA for Treatment of Triple Negative Breast Cancer (TNBC)

Lantern Pharma Inc. (NASDAQ LTRN), an artificial intelligence (AI) company dedicated to developing cancer therapies and transforming the cost, pace, and timelin

FDA Grants Breakthrough Therapy Designation to Sacituzumab Tirumotecan (sac-TMT) for the Treatment of Certain Patients With Previously Treated Advanced or Metastatic Nonsquamous Non-Small Cell Lung Cancer With EGFR Mutations

Merck (NYSE MRK), known as MSD outside of the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthroug

Deep Belly Fat May Help Spur Alzheimer's Decades Before Symptoms Begin

An accumulation of fat lurking around the organs of obese people is strongly linked to a buildup of Alzheimer s-linked proteins in the brain, new research finds

New Weight-Loss Advance: A Gastric Balloon You Control to Feel Full or Not

GLP-1 meds are all the rage for weight loss nowadays, but not everyone can safely take the drugs to shed pounds. Invasive weight-loss surgeries can often be a t

Incidence of HIV Lower With Twice-Yearly Subcutaneous Lenacapavir

In a population of cisgender men, transgender women, transgender men, and gender-nonbinary persons, the incidence of HIV is lower with receipt of twice-yearly s

Nocturnal Enuresis More Common in Children With Sleep Apnea

Nocturnal enuresis is more common in children with obstructive sleep apnea (OSA), according to a study published online Sept. 23 in Children. Mar a Andreu-Codin

Antiobesity Medications Tied to Decreased Alcohol Use

Nearly half of participants in a weight loss program who initiated an antiobesity medication and who consumed alcohol at baseline reported decreases in their al

Current Prenatal Multivitamin, Mineral Labels Are Misleading

Current prenatal multivitamin and mineral (PMVM) labels are misleading and often exclude the presence of heavy metals, according to a study published online Nov

Two Common Antiseizure Medications Do Not Harm Child Neurodevelopment

Fetal exposure to two common antiseizure medications (ASMs) does not seem to negatively impact children s neurological development at age 6 years, according to